NCT06001658 2025-12-03Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract CancersSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2 Recruiting27 enrolled